These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 29073797

  • 1. Features of polycystic ovary syndrome (PCOS) in women with functional hypothalamic amenorrhea (FHA) may be reversible with recovery of menstrual function.
    Carmina E, Fruzzetti F, Lobo RA.
    Gynecol Endocrinol; 2018 Apr; 34(4):301-304. PubMed ID: 29073797
    [Abstract] [Full Text] [Related]

  • 2. Polycystic Ovary-Like Abnormalities (PCO-L) in women with functional hypothalamic amenorrhea.
    Robin G, Gallo C, Catteau-Jonard S, Lefebvre-Maunoury C, Pigny P, Duhamel A, Dewailly D.
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4236-43. PubMed ID: 22948766
    [Abstract] [Full Text] [Related]

  • 3. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea.
    Carmina E, Fruzzetti F, Lobo RA.
    Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792
    [Abstract] [Full Text] [Related]

  • 4. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.
    Akush Ginekol (Sofiia); 2013 Jun; 52 Suppl 1():16-23. PubMed ID: 24294740
    [Abstract] [Full Text] [Related]

  • 5. Anti-Müllerian Hormone and Ovarian Morphology in Women With Hypothalamic Hypogonadism.
    Alemyar A, van der Kooi ALF, Laven JSE.
    J Clin Endocrinol Metab; 2020 May 01; 105(5):. PubMed ID: 32170295
    [Abstract] [Full Text] [Related]

  • 6. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S, Laven JSE, Duhamel A, Dewailly D.
    Hum Reprod; 2017 Aug 01; 32(8):1723-1731. PubMed ID: 28854584
    [Abstract] [Full Text] [Related]

  • 7. Parallel variations of insulin-like peptide 3 (INSL3) and antimüllerian hormone (AMH) in women with the polycystic ovary syndrome according to menstrual cycle pattern.
    Pelusi C, Fanelli F, Pariali M, Zanotti L, Gambineri A, Pasquali R.
    J Clin Endocrinol Metab; 2013 Oct 01; 98(10):E1575-82. PubMed ID: 23928669
    [Abstract] [Full Text] [Related]

  • 8. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
    Somunkiran A, Yavuz T, Yucel O, Ozdemir I.
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct 01; 134(2):196-201. PubMed ID: 17335955
    [Abstract] [Full Text] [Related]

  • 9. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.
    Acta Obstet Gynecol Scand; 2013 Dec 01; 92(12):1369-74. PubMed ID: 23980726
    [Abstract] [Full Text] [Related]

  • 10. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA, Lee P, Smith HC.
    Aust N Z J Obstet Gynaecol; 2017 Oct 01; 57(5):552-557. PubMed ID: 28597496
    [Abstract] [Full Text] [Related]

  • 11. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.
    Hum Reprod; 2005 Jul 01; 20(7):1820-6. PubMed ID: 15802325
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of diminished ovarian reserve in Chinese women with polycystic ovary syndrome and sensitive diagnostic parameters.
    Jin J, Ruan X, Hua L, Tian X, Li Y, Wang L, Mueck AO.
    Gynecol Endocrinol; 2017 Sep 01; 33(9):694-697. PubMed ID: 28412857
    [Abstract] [Full Text] [Related]

  • 13. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S, van der Spuy ZM.
    Ultrasound Obstet Gynecol; 1996 May 01; 7(5):335-41. PubMed ID: 8774098
    [Abstract] [Full Text] [Related]

  • 14. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y, Wei LN, Xiong YL, Liang XY.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 01; 45(8):567-70. PubMed ID: 21029609
    [Abstract] [Full Text] [Related]

  • 15. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
    Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.
    Syst Biol Reprod Med; 2015 Apr 01; 61(2):103-9. PubMed ID: 25329139
    [Abstract] [Full Text] [Related]

  • 16. AMH in combination with SHBG for the diagnosis of polycystic ovary syndrome.
    Calzada M, López N, Noguera JA, Mendiola J, Hernández AI, Corbalán S, Sanchez M, Torres AM.
    J Obstet Gynaecol; 2019 Nov 01; 39(8):1130-1136. PubMed ID: 31208261
    [Abstract] [Full Text] [Related]

  • 17. Serum LH levels are associated to serum insulin and Anti-Müllerian hormone levels in women with both functional hypothalamic amenorrhoea and polycystic ovarian morphology.
    Makolle S, Catteau-Jonard S, Robin G, Dewailly D.
    Clin Endocrinol (Oxf); 2023 Jul 01; 99(1):73-78. PubMed ID: 36912207
    [Abstract] [Full Text] [Related]

  • 18. Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels.
    Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D.
    Am J Physiol Endocrinol Metab; 2009 Feb 01; 296(2):E238-43. PubMed ID: 18957615
    [Abstract] [Full Text] [Related]

  • 19. Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results.
    Yetim A, Yetim Ç, Baş F, Erol OB, Çığ G, Uçar A, Darendeliler F.
    J Clin Res Pediatr Endocrinol; 2016 Sep 01; 8(3):288-97. PubMed ID: 27125339
    [Abstract] [Full Text] [Related]

  • 20. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
    Łebkowska A, Adamska A, Karczewska-Kupczewska M, Nikołajuk A, Otziomek E, Milewski R, Górska M, Wołczyński S, Kowalska I.
    Metabolism; 2016 May 01; 65(5):804-811. PubMed ID: 26961579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.